SIGA News and Press, SIGA Technologies Inc. From 08/04/22

A group of public health officials from several federal agencies penned an editorial in the New England Journal of Medicine defending a recent U.S. FDA statement that SIGA Technologies' ( NASDAQ: SIGA ) Tpoxx (tecovirimat) has not demonstrated efficacy in humans fo...

The Biden administration is expected to declare the current monkeypox outbreak a public health emergency as soon as Thursday, The Washington Post reported Thursday. The Health and Human Services Secretary Xavier Becerra is expected to make the announcement at an afternoon briefing...

Vaccine maker Bavarian Nordic (OTC: BVNR.Y) and antiviral producer Siga Technologies (NASDAQ: SIGA) appear to be the early leaders in monkeypox prevention and treatment. Quest Diagnostics (NYSE: DGX) has the capacity to run 30,000 tests per week, and is expected to b...

NanoViricides ( NYSE: NNVC ) said it has begun drug development to fight the monkeypox virus. The company started a program to screen its library of broad-spectrum antiviral nanoviricides against certain poxviruses to develop broad-spectrum poxvirus therapies that act ...

DEEP implements a 4-step methodology to select discounted small caps. More than 30% of asset value is in consumer discretionary. Past performance is underwhelming relative to a small cap value benchmark. DEEP strategy and portfolio The Roundhill Acquirers Deep Va...

Monkeypox stocks are beginning to capture broad market attention, and, yes, penny stocks are among the most speculated upon. But there are a few things you have to understand when approaching this niche. Like COVID stocks, more assumptions are being made about “what might happen&...

President Joe Biden appointed two top federal officials to lead the U.S. response against monkeypox, the White House announced Tuesday, as the ongoing outbreak has prompted more states to declare emergencies to contain the virus. Robert Fenton, who currently serves as Regional Admin...

Check Out These Three MonkeyPox Stocks Making Headlines In The Stock Market Today Unless you’ve been living under a rock, it’s likely you’ve seen all the monkeypox headlines in the stock market today. Health authorities worldwide are actively looking for a w...

After the FDA provided an update on the agency's response to the monkeypox outbreak on July 29th, investors misunderstood the FDA's statements, and the stock sold off 33% and shortly reverted. SIGA's monkeypox treatment TPOXX is already approved in the U.S., EU, and Canada for smallpo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Monkeypox stocks are rallying amid worries about a shortage of vaccines for the illness in the U.S. Additionally, in recent days, New York state , New York City and San Francisco have issued emergency orders related to m...